Evidence Synthesis
AJANTPHARM's 77.22% gross margin accelerated, up from 25.2%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 13 Sept 2026, 00:09
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AJANTPHARM's 77.22% gross margin accelerated, up from 25.2%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 77.22 % | 25.2 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 25.2 % | 19.65 | ▲ |
| REVENUE_GROWTH_YOY | 24.8 % | 30.8 | ▼ |
| EPS_ACTUAL | 20.82 INR | 21.91 | ▼ |
| EPS_SURPRISE_PERCENT | -0.038 % | 0.104 | ▼ |
| PRICE_CHANGE_PERCENT | 0.381 % | — | - |
| DAILY_VOLUME | 45,544 shares | 1,07,419 | ▼ |
| CLOSE_PRICE | 3,533.4 INR | 3,520 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.71 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 10 | ▼ |
| TARGET_PRICE_PREMIUM | 6.44 % | — | - |